A comparison between the solid state conformation of phenmetrazine and the alpha-sympathomimetic pharmacophore pattern. 1975

H Moereels, and J P Tollenaere

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D010633 Phenmetrazine A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. Defenmetrazin,Fenmetrazin,Oxazimedrine,Phenmetraline,Phenmetrazine Hydrochloride,Preludin,Hydrochloride, Phenmetrazine
D011789 Quantum Theory The theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E Quantum Theories,Theories, Quantum,Theory, Quantum
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic

Related Publications

H Moereels, and J P Tollenaere
January 1995, International journal of peptide and protein research,
H Moereels, and J P Tollenaere
January 2003, Biopolymers,
H Moereels, and J P Tollenaere
September 1997, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society,
H Moereels, and J P Tollenaere
January 1971, European journal of pharmacology,
H Moereels, and J P Tollenaere
August 2004, Organic & biomolecular chemistry,
H Moereels, and J P Tollenaere
June 1986, Journal of pharmaceutical sciences,
H Moereels, and J P Tollenaere
August 1994, Pharmaceutical research,
H Moereels, and J P Tollenaere
January 2008, Bioorganic & medicinal chemistry,
H Moereels, and J P Tollenaere
September 1985, Biopolymers,
Copied contents to your clipboard!